CTNM Intrinsic Valuation and Fundamental Analysis - Contineum Therapeutics Inc

C	Contineum Therapeutics Inc NASDAQ:CTNM	US
	Guillemot Corporation SA PAR:GUI	FR
A	Ardelyx Inc F:41X	US
D	DBS Group Holdings Ltd XBER:DEVL	SG
T	Teekay Corp F:TCD	BM
	BCM Resources Corp OTC:BCMRF	CA
C	Carpenter Technology Corp F:XTY	US
E	Energy Fuels Inc F:VO51	US
K	Kirin Holdings Co Ltd DUS:KIR	JP
K	Kajima Corp DUS:KAJ	JP
S	Shiseido Co Ltd XMUN:SHD	JP
T	TPI Polene Power PCL SET:TPIPP	TH
O	Oracle Corp DUS:ORC	US
F	Firetrade Engineering PCL SET:FTE	TH
	Holding Company ADMIE IPTO SA OTC:HCAEF	GR
	Lucid Group Inc F:CH2A	US
	Beneteau SA OTC:BTEAF	FR
	Critical Elements Lithium Corp F:F12	CA

Intrinsic Value

The intrinsic value for Contineum Therapeutics Inc (CTNM) under the Base Case is hidden USD. Compared with the current market price of 16.7 USD, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

Wall St target

$23.9

Do our valuations actually work? See backtest results .

CTNM Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with CTNM’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price $16.7

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Contineum Therapeutics Inc.

Explain Valuation